Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells by Tochigi, Hideno et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Tochigi, Hideno, Kajihara, Takeshi, Mizuno, Yosuke, Mizuno, Yumi, Tamaru, Shunsuke, 
Kamei, Yoshimasa, Okazaki, Yasushi, Brosens, Jan J. and Ishihara, Osamu. (2017) Loss of miR-
542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. 
Scientific Reports, 7 . 40001. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/85074                 
       
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work of researchers of the 
University of Warwick available open access under the following conditions. 
 
This article is made available under the Creative Commons Attribution 4.0 International 
license (CC BY 4.0) and may be reused according to the conditions of the license.  For more 
details see: http://creativecommons.org/licenses/by/4.0/   
 
A note on versions: 
The version presented in WRAP is the published version, or, version of record, and may be 
cited as it appears here. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
1Scientific RepoRts | 7:40001 | DOI: 10.1038/srep40001
www.nature.com/scientificreports
Loss of miR-542-3p enhances 
IGFBP-1 expression in decidualizing 
human endometrial stromal cells
Hideno Tochigi1,2, Takeshi Kajihara1, Yosuke Mizuno2, Yumi Mizuno1, Shunsuke Tamaru1,2, 
Yoshimasa Kamei1, Yasushi Okazaki2,3, Jan J Brosens4,5 & Osamu Ishihara1
Endometrial decidualization represents an essential step for the successful implantation of the 
embryo; however, the molecular mechanism behind this differentiation process remains unclear. 
This study aimed to identify novel microRNAs (miRNAs) involved in the regulation of decidual gene 
expression in human endometrial stromal cells (HESCs). An in vitro analysis of primary undifferentiated 
and decidualizing HESCs was conducted. HESCs were isolated from hysterectomy specimens from 
normally cycling premenopausal women with uterine fibroids, who were not on hormonal treatment 
at the time of surgery. Primary HESCs were expanded in culture and decidualized with 8-bromo-cyclic 
adenosine monophosphate and medroxyprogesterone acetate. Microarray analysis identified six 
miRNAs differentially expressed in response to decidualization of HESCs. All but one miRNA were 
downregulated upon decidualization, including miR-542-3p. We demonstrated that miR-542-3p 
overexpression inhibits the induction of major decidual marker genes, including IGFBP1, WNT4 and 
PRL. In addition, miR-542-3p overexpression inhibited the morphological transformation of HESCs in 
response to deciduogenic cues. A luciferase reporter assay confirmed that the 3′-untranslated region of 
IGFBP1 mRNA is targeted by miR-542-3p. The results suggest that miR-542-3p plays an important role 
in endometrial decidualization by regulating the expression of major decidual marker genes.
Initiation of pregnancy represents the successful combination of two independent processes, i.e. embryo develop-
ment and endometrial differentiation. Decidualization denotes the morphological and biochemical transforma-
tion of the human endometrial stromal cells (HESCs) into decidual cells, which regulate blastocyst implantation 
and subsequent placenta formation1,2. In contrast to many other mammals, decidualization of HESCs is inde-
pendent of the presence of an implanting blastocyst and is initiated during the mid- to late-luteal phase of the 
cycle. The most striking morphological alteration of the decidual process is the dramatic transformation of the 
endometrial stromal fibroblasts into secretory epithelioid decidual cells3. At a molecular level, decidual transfor-
mation involves extensive reprogramming of many cell functions, mediated by the activation of key transcription 
factors, including progesterone receptor, forkhead box protein O1 (FOXO1), CCAAT/enhancer-binding protein 
beta (C/EBPβ ) and the homeobox proteins HOXA10 and HOXA11. The convergence of these transcription fac-
tors on promoters of key genes drives the expression and secretion of major decidual factors, including prolactin 
(PRL), WNT4 and insulin-like growth factor binding protein-1 (IGFBP-1)3,4.
MicroRNAs (miRNAs) are single-stranded small non-coding RNAs of approximately 22 nucleotides that reg-
ulate gene expression by blocking the translation or by decreasing the stability of mRNAs5. In mammals, miRNAs 
are predicted to control the activity of approximately 50% of all protein-coding genes6,7. The majority of mamma-
lian microRNAs are spatiotemporally regulated. Accumulating evidence has implicated miRNAs in the regulation 
of numerous biological processes, ranging from proliferation, differentiation and apoptosis to embryo develop-
ment and implantation8. In addition, aberrant miRNA expression is a feature of many pathological conditions, 
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including cancer, viral infections, metabolic diseases and neurological disorders9. However, our understanding 
of the expression, regulation and function of miRNAs in differentiating HESCS remains limited. Hence, we 
employed both miRNA and gene expression microarrays to identify miRNAs and target genes that are regulated 
upon decidual transformation of HESCs. We show that miR-542-3p is a potent negative regulator of HESC differ-
entiation in response to deciduogenic cues.
Results
Differentially expressed miRNAs upon decidualization. The efficiency of decidualization in primary 
HESC cultures was confirmed by observing morphological changes and by measuring PRL secretion, the princi-
pal decidual marker10,11. HESCs exhibited a spindle-shaped fibroblast-like appearance when propagated in culture 
but acquired the typical morphology of decidual cells, i.e. an enlarged cell size with larger nuclei and abundant 
cytoplasm, upon treatment with 8-bromo-cyclic adenosine monophosphate (8-br-cAMP) and medroxyproges-
terone acetate (MPA) for 6 days (Fig. S1A). Furthermore, PRL secretion markedly increased in response to the 
treatment with 8-br-cAMP and MPA for 6 days (Fig. S1B).
To identify miRNAs differentially expressed after 6 days of differentiation, 3 paired undifferentiated and 
decidualizing HESC cultures were subjected to miRNA microarray analysis. miRNAs consistently upregulated 
(> 2-fold) or downregulated (< 0.5-fold) in pair-wise comparison of the 3 biological repeat experiments were 
extracted. Among the 1,205 sets of human miRNAs covered by the array, five (miR-503, miR-542-3p, miR-155, 
miR-145* and miR-424) were significantly down-regulated upon decidualization (< 0.5-fold) (Table 1A), whereas 
a single miRNA (miR-483-3p) increased in expression (> 2-fold) (Table 1B) in all three decidualizing primary 
HESC cultures (Fig. 1A and Table 1A and B).
Identification of decidual target genes. Hundreds of candidate target genes for each differentially 
expressed miRNA were predicted on public miRNA databases. The expression of most of these putative target 
genes will be down-regulated upon binding of miRNA to complementary seed sequences in target transcripts6,7. 
To identify miRNA target genes relevant to decidualization, we performed gene expression microarrays on the 
same RNA samples used in miRNA array analysis. This analysis identified six major induced decidual genes that 
were also putative targets of miR-542-3p, miR-424 or miR-503 (Table 2). We reasoned that induction of these 
decidual genes could be dependent upon the down-regulation of targeting miRNAs. We then focused on miR-
542-3p and its putative target IGFBP1, which encodes for the major decidual secretory protein4,12. Differential 
expression of miR-542-3p was confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) analysis 
(Fig. 1B). qRT-PCR analysis also confirmed the marked induction of IGFBP1 in HESCs treated with 8-br-cAMP 
and MPA (Fig. 1C).
Decidualisation is inhibited by miR-542-3p. To determine the functional significance of the loss of miR-
542-3p expression in differentiating HESCs, primary cultures were transfected with either miR-542-3p mimic or 
negative control miRNA mimic prior to decidualization over a time course lasting 6 days. To assess potential tox-
icity of transfection, cell apoptosis/necrosis detection assay was performed. The abundance of apoptotic/necrotic 
cells did not differ between the experimental groups (P > 0.05; Fig. S2). In cells transfected with negative control 
miRNA mimic, differentiating HESCs displayed distinct morphological characteristics, whereas this response 
was completely lacking in cultures transfected with the miR-542-3p mimic (Fig. 2A). To evaluate transfection 
efficiency, we have performed qRT-PCR for miR542-3p. Compared with cells transfected with control miRNA 
mimic, the expression of miR-542-3p in response to 8-br-cAMP and MPA treatment was markedly up-regulated, 
approximately 2,200-fold, in cultures expressing miR-542-3p mimic (Fig. S3). The expression of IGFBP1 was 
also evaluated using qRT-PCR analysis. The expression of IGFBP1 in HESCs treated with 8-br-cAMP and MPA 
increased in a time-dependent manner (Fig. 2B). Compared to cells transfected with control miRNA mimic, 
the induction of IGFBP1 transcripts in response to 8-br-cAMP and MPA treatment was markedly inhibited in 
cultures transfected with the miR-542-3p mimic (Fig. 2B). The expression of the other decidual markers was also 
examined. Similar to IGFBP1, the induction of PRL and WNT4 was repressed by miR-542-3p mimic (Fig. 2B). 
To clarify whether inhibition of PRL and WNT4 expression was a direct effect of miR-542-3p or an indirect 
effect caused by IGFBP1 knockdown, we transfected primary cultures with either non-targeting small interfer-
ing RNA (siRNA) or siRNA targeting IGFBP1. Following transfection, the HESC cultures were decidualized 
for 6 days. Similar to miR-542-3p mimic transfection, IGFBP1 knockdown was sufficient to impair PRL and 
miRNA Fold-change p value
(A) Down-regulated miRNA
hsa-miR-503 0.20 0.0227
hsa-miR-542-3p 0.30 0.0085
hsa-miR-155 0.38 0.0074
hsa-miR-145* 0.39 0.0047
hsa-miR-424 0.40 0.0030
(B) Up-regulated miRNA
hsa-miR-483-3p 10.39 0.0448
Table 1.  Differentially expressed miRNAs upon decidualization of primary HESCs.
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WNT4 expressions (Fig. 2C), suggesting that IGFBP-1 itself plays a role in regulating other decidual marker 
genes. Further, the decrease in IGFBP-1 secretion by miR-542-3p was confirmed by an enzyme-linked immuno-
sorbent assay (ELISA) assay of the culture supernatants (Fig. S4). Taken together, these results demonstrate that 
miR-542-3p is a potent inhibitor of HESC differentiation.
IGFBP1 is a bona fide target of miR-542-3p. To examine if miR-542-3p targets IGFBP1 directly, a 
reporter construct was generated by inserting the putative binding site of miR-542-3p into the 3′ untranslated 
region (UTR) of the IGFBP1 gene downstream of a firefly luciferase reporter vector (IGFBP1-wt). The seed 
sequence of the target site was also mutated to generate a control plasmid (IGFBP1-mut) (Fig. 3A). As shown 
in Fig. 3B, luciferase activity was decreased upon co-transfection of decidualized HESCs with the IGFBP1-wt 
reporter construct and miR-542-3p mimic when compared to co-transfection with a control miRNA mimic 
Figure 1. Identification of miRNAs involved in decidualization. (A) Scatter plot of miRNA microarray 
results. Total RNA from three independent HESC cultures, decidualized or not, were labelled and hybridised 
separately on the Agilent miRNA microarray, and signal intensity, which corresponds to the expression level 
of each miRNA, was measured. The intensity was averaged and converted to a log2 value. Expression level of 
each miRNA is shown as a scatter plot. The level of expression in undifferentiated and decidualizing HESCs is 
shown on the Y-axis and X-axis, respectively. qRT-PCR analysis of miR-542-3p and IGFBP1 mRNA expression 
in undifferentiated and differentiating HESCs in samples used for microarray experiments. (B) The level of 
miR-542-3p (miR-542-3p/U6 ratio) expression in HESCs treated with 8-br-cAMP and MPA for 6 days was 
significantly down-regulated in comparison to untreated HESCs. (C) IGFBP1 mRNA expression, normalized to 
GAPDH mRNA (glyceraldehyde phosphate dehydrogenase), in HESCs treated with 8-br-cAMP and MPA for 6 
days was significantly up-regulated in comparison to undifferentiated HESCs. The experiments were performed 
using three independent primary cell cultures. The data are shown as mean ± SEM. **P < 0.01.
www.nature.com/scientificreports/
4Scientific RepoRts | 7:40001 | DOI: 10.1038/srep40001
(P < 0.05). In contrast, no differences were found when the cells were transfected with the IGFBP1-mut reporter. 
Taken together, the data confirms that miR-542-3p inhibits IGFBP1 expression by binding to its 3′ UTR.
Discussion
In the current study, we combined miRNA and mRNA microarray analyses of primary HESC cultures to identify 
novel decidual regulators. We identified five miRNAs robustly repressed and a single miRNA consistently induced 
upon decidual transformation of HESCs. Parallel transcriptional profiling enabled us to identify the miRNA–
mRNA pairs that functionally regulate decidualization. We focused on miR-542-3p and its predicted target gene 
IGFBP1, a well-known decidual marker4,12, for further analysis. We were able to demonstrate that miR-542-3p 
directly regulates IGFBP1 expression during HESCs and indirectly regulates the expression of other decidual 
marker genes, such as PRL and WNT4.
As small non-coding RNAs, miRNAs are classified as regulatory RNAs and have been reported to have vari-
ous roles, including cell growth, proliferation and differentiation8. Because each miRNA is predicted to target a 
broad range of mRNAs based on the degree of sequence homology, the expression of approximately 50% of all 
protein-coding genes are estimated to be subjected to miRNA regulatory function6,7. The inverse relationship 
between the expression of miRNAs and their target genes is complex and evolving. Notably, aberrant miRNA 
expression has been associated with endometrial disorders, including endometriosis, endometrial hyperplasia 
and carcinoma13,14. On the other hand, it has been reported that miR-542-3p is generally underexpressed in can-
cers arising from the colon, prostate and lung. Further, overexpression of miR-542-3p can inhibit cell growth and 
prevent tumour formation in vivo15. These observations suggest that miR-542-3p is a promising target for cancer 
therapy. On the other hand, Kureel et al. demonstrated that miR-542-3p suppresses osteogenic differentiation and 
promotes osteoblast apoptosis by repressing bone morphogenetic protein 7 and its downstream signalling16. To 
the best of our knowledge, the current report is the first to identify that miR-542-3p directly regulates morpho-
logical and biological differentiation of HESCs through targeting IGFBP1 expression.
We and others previously reported that Dicer knockdown does not block HESCs decidualization17,18. Female 
mice lacking Dicer in the reproductive tract are infertile due to defective oviducts but exhibited histologically 
normal decidual responses. Therefore, we speculated that miRNAs may primarily serve to prevent premature or 
illicit activation of decidual genes. Endometrial expression of miRNAs upon decidualization has been studied in 
few other species and, as aforementioned, some functional studies have been carried out in rodents19–21. Members 
of three miRNAs families, including Let-7 Family, miR-200 Family, and miR-30 Family, are frequently identified 
as differentially expressed in these studies22. To the best of our knowledge, the current report is the first to iden-
tify that miR-542-3p directly regulates morphological and biological differentiation of HESCs through targeting 
IGFBP1 expression.
Uterine expression of cyclooxygenase-2 is regulated by miR-101a and miR-199a* at implantation in mice23. 
Expression profiling of miRNAs during the menstrual cycle demonstrated that they are regulated by ovarian hor-
mones18,24. Further, recent reports demonstrate that aberrant miRNA expression is associated with reproductive 
disorders, including endometriosis, endometrial hyperplasia and carcinoma13,14. The present study identified six 
miRNAs differentially expressed in response to decidualization of HESCs. On the other hand, Estella et al.17 found 
a total of 26 and 17 miRNAs up- and down-regulated, respectively, upon decidualization. Among these miRs, 
only miR-155 was identified as an induced miRNA upon decidualization in both studies. Further, Estella et al. 
found no significant change in the expression of miR-542-3p, which may be due to the differences in endometrial 
samples, decidualization protocol, or the expression profiling technique. Perhaps most notable, decidualization 
in the study of Estella et al. was induced by a combination of estradiol and progesterone, which is a much weaker 
HESCs differentiation stimulus than treatment with a cAMP analogue and MPA25,26.
IGFBP-1 is widely used as phenotypic markers of decidualization but its involvement in the regulation of this 
transformational process has been largely ignored. Decidual IGFBP-1 is thought to have IGF-dependent and 
IGF-independent actions on trophoblast invasion at implantation12. Importantly, exposure of HESCs to recom-
binant human IGFBP-1 has been reported to promote morphological decidual transformation and increase PRL 
secretion by interacting with α 5β 1 integrin expressed on the surface of HESCs27. These observations strongly 
infer an auto/paracrine role IGFBP1 in enhancing decidual transformation of HESCs. Transfection of HESCs 
with miR-542-3p inhibited PRL and WNT4 expression after 6 days of decidualization by 60–70%. However, trans-
fection of cells with siRNA targeting IGFBP1 decreased PRL and WNT4 mRNA levels much more modestly 
(∼ 20%). This discrepancy may reflect the ability of a single miR to target multiple mRNAs and, conversely, 
that a single mRNA can be targeted by multiple miRs28. Therefore, repression of PRL and WNT4 expression in 
miRNA Target gene Gene name Fold change*1
miR-542-3p
IGFBP1 insulin-like growth factor binding protein 1 232.16
WNT4 wingless-type MMTV integration site family, member 4 73.93
miR-424
FOXO1 forkhead box O1 10.07
IGF1 insulin-like growth factor 1 (somatomedin C) 7.43
GADD45G growth arrest and DNA-damage-inducible, gamma 40.20
miR-503
IGF2 insulin-like growth factor 2 (somatomedin A) 8.47
IGF1 insulin-like growth factor 1 (somatomedin C) 7.43
Table 2.  Predicted decidual target genes. The expression of all putative target genes changed > 2-fold in either 
direction upon decidualization.
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decidualizing HESCs upon transfection with miR-542-3p mimic likely involves mechanisms other than the inhi-
bition the auto/paracrine actions of IGFBP-1. Clearly, additional experiments are required to test this hypothesis.
Our study has several limitations. Although the decidualization of primary HESCs is a well-established model, 
the absence of other cellular constituents of the endometrium, e.g. epithelial or vascular cells, may impact on the 
Figure 2. Effect of miR-542-3p overexpression or IGFBP-1 knockdown in decidualizing HESCs.  
(A) Morphological changes of HESCs transfected with miR-542-3p mimic. HESCs transfected with negative 
control miRNA mimic (NC mimic) showed morphological changes characteristic of decidual cells upon 
treatment with 8-br-cAMP and MPA for 6 day. By contrast, morphological transformation was absent upon 
transfection of cells with miR-542-3p mimic. Scale bars = 100 μ m. (B) qRT-PCR analysis of IGFBP1, PRL 
and WNT4 transcript levels in HESCs transfected with a miR-542-3p mimic or NC mimic and decidualized 
for. 6 days. Expression levels were normalised to GAPDH. Data represent mean ± SEM of three independent 
experiments. (C) qRT-PCR analysis IGFBP1, PRL and WNT4 transcript levels in HESCs transfected with siRNA 
targeting IGFBP-1 and then decidualized for 6 days. Expression levels were normalised to GAPDH. Data are the 
mean ± SEM of three independent experiments **P < 0.01, *P < 0.05.
www.nature.com/scientificreports/
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results. Furthermore, all primary cultures were established from patients requiring surgery for uterine fibroids 
as it is challenging to obtain biopsies from women who are free of gynaecological diseases. Although the current 
study focused on miR-542-3p, other differentially expressed miRNAs, including miR-424, miR-503 and miR-155, 
may equally functionally regulate decidualization. Interestingly, it has been reported that miR-424 and miR-503 
are derived from a polycistronic precursor miR-424-503. These miRNAs were reported to have combinatorial 
effects within the cellular system29. It is possible that miR-424 in cooperation with miR-503 coordinates endo-
metrial differentiation. Although only miR-542-3p was intensively investigated in the present study, the detailed 
roles of other miRNAs should be explored in a future study.
In conclusion, the present study demonstrates that the downregulation of miR-542-3p expression in HESCs is 
permissive for morphological and molecular differentiation of HESCs. Our results indicate that miR-542-3p plays 
an important role in endometrial decidualization, at least in part, by regulating IGFBP1 expression.
Methods
Experimental ethics policy. The protocol of the current study was approved by the Institutional Review 
Board of the Saitama Medical University Hospital (11-017-1). This study was carried out in accordance with the 
approved guideline. Written informed consent was obtained from all participating subjects.
Tissue collection and isolation of HESCs. HESCs were obtained at the time of hysterectomy for uterine 
fibroids from normally cycling premenopausal women. Patients were not undergoing hormonal treatment at the 
time of surgery. All the samples were collected during the proliferative phase of the cycle. HESCs were isolated 
Figure 3. IGFBP1 is a direct target of miR-542-3p. (A) The predicted target sequence of miR-542-3p in the  
3′ untranslated region (UTR) of IGFBP1 and the mutated sequence used in the luciferase assay are shown.  
(B) Relative luciferase activity of IGFBP1-wt and IGFBP1-mut reporter vectors co-transfected with miR-542- 
3p mimic (miR-542-3p) or negative control (NC) miRNA in decidualized HESCs. Using IGFBP1-wt vector, 
the relative luciferase activity was decreased by 31% upon transfection with miR-542-3p compared to NC 
mimic. The IGFBP1-mut reporter was not significantly inhibited by miR-542-3p mimic. Data are shown as the 
mean ± SEM of three independent experiments. *P < 0.05; NS, Not significantly different.
www.nature.com/scientificreports/
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and cultured as previously described30–32. Briefly, endometrial samples were collected in Dulbecco’s modified 
Eagle’s medium (DMEM)/F-12 containing Antibiotic-Antimycotic solution (Invitrogen). After enzymatic diges-
tion by DNase I (Sigma) and Collagenase I a (Sigma), the stromal cells were separated from epithelial cells and 
passed into culture. Proliferating HESCs were cultured in maintenance medium of DMEM/F-12 containing 10% 
dextran-coated charcoal-treated FBS and 1% antibiotic–antimycotic solution (Life technologies). Confluent mon-
olayers of HESCs were treated with or without 0.5 mM 8-bromo-cyclic adenosine monophosphate (8-br-cAMP; 
Sigma) and 10−6 M medroxyprogesterone acetate (MPA; Sigma). All experiments were conducted before the third 
passage of the cultures.
Measurement of PRL and IGFBP1. The concentration of PRL in the HESC culture media was meas-
ured by microparticle enzyme immunoassay (AxSYM system; Abbott Laboratories, North Chicago, IL). The 
level of IGFBP1 in culture media was determined using a sandwich-type immunoassay (Mediagnost, Reutlingen, 
Germany). The assay was performed in triplicate or duplicate and normalised to the total protein content of 
cultures.
RNA extraction. Total RNA was purified from HESCs using the miRNeasy Mini kit (Qiagen, Valencia, CA, 
USA) according to the manufacturer’s protocol. RNA quality was verified by measuring the absorbance at 230 nm, 
260 nm and 280 nm using a NanoDrop spectrometer (NanoDropTechnology, San Diego, CA, USA).
miRNA expression array. The analysis of the miRNA microarray was performed using a commercial human 
miRNA microarray (G4872A Human Rel. 16.0, Agilent Technologies, Santa Clara, CA, USA), which included 
probes for 1,205 human and 144 viral miRNAs based on Sanger miRBase Release 16.0. Total RNA samples from 
three independent, undifferentiated and decidualizing HESC cultures, were subjected to miRNA microarray. 
Using 100 ng of total RNA of each of the 6 samples, miRNAs were labelled and hybridised onto the miRNA 
microarray using the miRNA Complete Labelling and Hybridisation Kit (Agilent Technologies), according to the 
manufacturer’s protocol. After hybridisation for 22 h, the miRNA array was washed and the signal intensity of 
an individual miRNA probe spot was measured using a microarray scanner (G2505B; Agilent Technologies) and 
quantified with Feature Extraction ver. 10.7.3.1 software (Agilent Technologies) (Supplementary excel file 1). The 
6 data sets were normalised using a quantile normalisation method33 (Supplementary Table S1). Expression of 
miRNAs was analysed pair-wise in undifferentiated and decidualising cells in the 3 biological repeat experiments. 
Upregulated and downregulated miRNAs were defined, respectively, by > 2-fold or < 0.5-fold change in expres-
sion level upon decidualization in pair-wise analysis of each of the 3 repeat experiments. The fold-change values 
of miRNAs were then calculated as average fold-change value from three independent paired cultures. P value 
was calculated by two-tailed Student’s t-tests.
Gene expression profiling. The RNA samples subjected to miRNA microarray analysis were also used to 
identify putative miRNA target genes. Briefly, total RNA from the 3 undifferentiated and 3 decidualized cultures 
were combined separately; and the two sets of mRNAs subjected to gene expression microarrays. Total RNA was 
reverse-transcribed, amplified and labelled using a GeneChip® 3′ IVT Expression Kit (Affymetrix Inc., Santa 
Clara, CA, USA). The complementary RNA (cRNA) was purified, fragmented according to the manufacturer’s 
protocol and hybridised on the Affymetrix GeneChip® Human Genome U133 Plus 2.0 array. Hybridisation, 
washing, staining and scanning were performed using the Affymetrix GeneChip® system instruments and pro-
tocols. The expression levels of each gene obtained from the scanned data were normalised among samples using 
the robust multi-array average (RMA) method. The mRNAs that were differentially upregulated (> 2-fold) or 
downregulated (< 0.5-fold) upon decidualization were extracted.
qRT-PCR for miRNAs. To confirm the relative expression level of objective miRNA, total RNA was sub-
jected to qRT-PCR analysis. The TaqMan microRNA RT kit (Applied Biosystems, Carlsbad, CA, USA) was used 
to synthesise cDNA from 5 ng of RNA. The PikoReal 96 Real-Time PCR system (Thermo Fisher Scientific Inc., 
Waltham, MA, USA) and TaqMan Universal Master Mix II with UNG (Applied Biosystems) were used to perform 
qRT-PCR in duplicate. TaqMan MicroRNA assays (Applied Biosystems) for miR-542-3p (Assay ID: MC001284) 
and U6 (as endogenous control) were used as primers for reverse transcription and amplification. The mature 
sequences of hsa-miR-542-3p were 5′ -UGUGACAGAUUG AUAACUGAAA-3′ (miRBase Accession number: 
MIMAT0003389). The expression level of miR-542-3p relative to U6 was calculated by the 2−ΔΔct method34.
qRT-PCR for mRNAs. Total RNAs of each sample were reverse transcribed using BioScript reverse 
transcriptase (Bioline, London, UK) with oligo dT primers, and cDNAs obtained were mixed with gene spe-
cific primers and Power SYBR Green PCR Master Mix (Applied Biosystems) and subjected to the qPCR 
analysis using the MX3000p system (Stratagene, La Jolla, CA, USA) or PikoReal 96 Real-Time PCR sys-
tem. Primer sequences for each genes were: 5′-CGACCACTTTGTCAAGCTCA-3′ [glyceraldehyde 
phosphate dehydrogenase (GAPDH)-forward], 5′-AGGGGTCTACATGGCAACTG-3′ (GAPDH-reverse); 5′ - 
CTGCGTGCAGGAGTCTGA-3′ (IGFBP1-forward), 5′ -CCCAAAGGATGGAATGATCC-3′ (IGFBP1-reverse); 
5′ -CTACATCCATAACCTC TCCTCA-3′ (PRL-forward), 5′ -GGGCTTGCTCCTTGTCTTC-3′ (PRL-reverse); 5′ - 
CAT GCAACAAGACGTCCAAG-3′ (WNT4-forward), 5′ -AAGCAGCACCAGTGGAATTT-3′ (WNT4-reverse). 
IGFBP1, PRL and WNT4 expression levels, relative to GAPDH, were calculated using the 2−ΔΔct method.
Identification of differentially expressed miRNAs. Array data for miRNA and mRNA were uploaded to the 
Ingenuity Pathways Analysis software (Ingenuity® Systems; www.ingenuity.com). Predicted target genes of differen-
tially expressed miRNAs were identified using TargetScan version 6.2 and the Ingenuity® Knowledge Base and filtered 
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on the basis of the direction of regulation of putative target genes in undifferentiated and decidualizing HESCs. The 
data for the differentially expressed mRNAs were integrated with miRNA expression data, using the IPA expression 
pairing function to obtain miRNA-mRNA relationships that showed expression change in the opposite directions.
Transfection of miRNA mimics and siRNA. Immediately prior to transfection, the culture medium 
of HESCs was changed to antibiotic-free decidualization medium containing 0.5 mM 8-br-cAMP and 10−6 M 
MPA. Control cultures were maintained at the standard medium. mirVanaTM miRNA mimic (#MC11340; 
Applied Biosystems) for hsa-miR-542-3p or siRNA targeting IGFBP1 (Silencer select, s7225; Applied Biosystems) 
was mixed with Lipofectamine 2000 (Invitrogen), according to the manufacturer’s instructions, and added to 
HESCs in six-well culture plates at a density of 80–90% confluence. Control cultures were transfected with con-
trol miRNA mimic or non-targeting siRNA. Final concentration of miRNA mimic and siRNA was 30 nM. After 
6 h and 3 days, cells were subjected to a change of antibiotics media to decidual differentiation with 0.5 mM 
8-br-cAMP and 10−6 M MPA or control media. Morphological evaluation, RNA extraction and qRT-PCR analysis 
were performed on day 6 of decidualization.
Reporter assay for the evaluation of the miRNA target. The miR-542-3p candidate target-
ing sequence of IGFBP1 gene (5′ -GAUGAAAUAAUGUUCUGUCACG-3′ , part of the NCBI RefSeq ID of 
NM_000596) and its mutated sequence (5′ -GAUGAAAUAAUGUUUCUGUGAG-3′ ) were inserted downstream 
of the pGL4.13 luciferase expression vector (Promega Corporation, Madison, WI, USA). The resulting constructs 
were named as IGFBP1-wt and IGFBP1-mut, respectively. Those two vectors with an amount of 200 ng and a final 
concentration of 30 nM miR-542-3p mimic were co-transfected to HESCS treated with 0.5 mM 8-br-cAMP and 
10−6 M MPA for 6 days before transfection. As a negative control, native pGL4.13 luciferase vector was also trans-
fected in parallel. For normalisation, 30 ng of Renilla luciferase vector, pGL4.74 (Promega), was also transfected 
into all samples. Transfections with all vectors and RNA combinations were repeated three times. After 48 h, the 
cells were harvested with PLB reagent (Promega), following which the firefly and Renilla luciferase activity was 
measured in each well using the dual luciferase assay kit (Promega) with the ARVO MX plate reader. The relative 
firefly luciferase activity was calculated by normalisation to the Renilla luciferase activity.
Cell apoptotic/Necrotic detection assay. To assess any potential toxicity of the miR-542-3p mimic 
transfection, apoptosis and necrosis were quantified by direct determination of nucleosomal DNA fragmenta-
tion using the Apoptotic/Necrotic/Healthy Cells Detection Kit (Takara bio Inc., Japan) as per the manufacture’s 
instructions.
Statistical analyses. All experiments were repeated a minimum of three times using independent primary 
cell cultures. All data were checked for their normal distribution using the Ronald-Fisher’s test, and if it was con-
sidered significant by the accuracy of P < 0.05, non-parametric statistical analysis was applied. Data are expressed 
as mean ± standard error (SE). Statistical analyses were performed by two-tailed Student’s t-tests. Results are 
presented as mean ± SE. P < 0.05 was considered significant.
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